New Delhi : IOL Chemical compounds and Prescription drugs has obtained the European Directorate for the High quality of Medicines and HealthCare’s (EDQM) Certificate of Suitability (CEP) to export paracetamol to the European market.
Established in 1986, a listed firm is likely one of the main pharmaceutical (APIs) corporations and is a major participant within the speciality chemical substances area. Paracetamol is often utilized in medication prescribed for ache reduction and to deal with fever.
“The certification issued by the EDQM verifies the compliance of pharmaceutical substances and with this backing, IOL will now be capable of export paracetamol to the European continent,” the pharma agency knowledgeable inventory exchanges on Monday.
The corporate began business manufacturing of paracetamol in 2022 in its Punjab-based facility. At current, it has a complete capability of three,600 tonnes to supply paracetamol.
Its abroad clients are unfold out throughout a number of nations together with the UK, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland, Poland, Eire, the US, Peru, Brazil, Argentina, Colombia, Indonesia, South Korea, Thailand, Bangladesh, Turkey, U.A.E., China, Hong Kong, Egypt.